Cerevast Therapeutics Garners $6,564,658 Series C Financing

  • Feed Type
  • Date
    12/13/2011
  • Company Name
    Cerevast Therapeutics
  • Mailing Address
    12277 134th Court NE Redmond, WA 98052
  • Company Description
    Cerevast Therapeutics, Inc. is a medical technology company with primary emphasis in the field of SonoLysis for the treatment acute ischemic stroke and other vascular disorders.
  • Website
    http://www.cerevast.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $6,564,658
  • Transaction Round
    Series C
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.